Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage

Clinical Infectious Diseases

Volumn 31, Issue 1, 2000, Pages 101-106

  Manikal, Vivek M ^a   Landman, David ^a   Saurina, Guillermo ^a   Oydna, Elyse ^b   Lal, Himal ^a   Quale, John ^a  

^a State University of New York Health Sciences University   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; POLYMYXIN; SULTAMICILLIN;

ACINETOBACTER; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; ENDEMIC DISEASE; FEMALE; GENETIC ANALYSIS; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; INSTITUTIONALIZATION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPECIES DIFFERENTIATION; WOUND INFECTION;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DRUG SYNERGISM; ELECTROPHORESIS, GEL, PULSED-FIELD; ENDEMIC DISEASES; HUMANS; NEW YORK CITY; PREVALENCE;

EID: 0034457383     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313902     Document Type: Article

References (36)

1. Nosocomial Acinetobacter baumannii infections: Microbiological and clinical epidemiology
2. Laboratory investigation of hospital outbreak caused by 2 different multiresistant Acinetobacter calcoaciticus subsp anitratus strains
3. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: Results of the case-control and molecular epidemiologic investigations
4. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit
5. Acinetobacter spp. As nosocomial pathogens: Microbiological, clinical, and epidemiological features
6. Use of macrorestriction analysis to demonstrate interhospital spread of multiresistant Acinetobacter baumannii in São Pãulo, Brazil
7. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam
8. Antibacterial drugs today. II
9. Antimicrobial combinations
10. In vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii
11. Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice
12. In-vitro activity of the combination of colistin and rifampin against multidrug-resistant strains of Acinetobacter baumannii
13. Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections
14. Correlation of 6 methods for typing nosocomial isolates of Acinetobacter baumannii
15. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
16. National nosocomial infections surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996 a report from the NNIS, System
17. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries
18. Antimicrobial activity and spectrum investigation of 8 broad-spectrum β-lactam drugs: A 1997 surveillance trial in 102 medical centers in the United States
19. In-vitro and in-vivo activities of antimicrobial agents against A cinetobacter calcoaceticus
20. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus
21. Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus
22. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium
23. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudonwnas aeruginosa and Acinetobacter baumannii
24. Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: Outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting
25. Plasmid DNA profiles of Acinetobacter baumannii: Clinical application in a complex endemic setting
26. Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: Correlation with amikacin usage
27. Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii
28. Control of an epidemic spread of a multi-resistant strain of Acinetobacter calcoaceticus in a hospital
29. Nosocomial acquisition of multi-resistant Acinetobacter baumannii: Risk factors and prognosis
30. Comparison of outbreak and non outbreak Acinetobacter baumannii strains by genotypic and phenotypic methods
31. Mechanisms of resistance to β-lactam antibiotics in Acinetobacter caleoaceticus
32. Imipenem resistance in Acinetobacter baumannii is due to altered penicillin-binding proteins
33. Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance
34. Carbapenem resistance mediated by β-lactamases in clinical isolates of Acinetobacter baumannii in Spain
35. Transferable imipenem-resistance in Acinetobacter species from a clinical source